Growing Inclination of Biopharmaceutical Companies towards Bi-Specific Antibodies
"Increasing numbers of companies are showing curiosity for the development of Bi-Specific Antibodies for the treatment of various diseases" says RNCOS
According to the RNCOS report entitled "Global Bi-Specific Antibodies Market Forecast to 2022", since the last few years, numerous companies have started showing interest in the development bi-specific antibodies. In March 2018, Merus N.V. announced the initiation of development of novel bi-specific antibodies for cancer therapeutics. The Company is developing these bi-specific antibodies in association with the Vall d'Hebron Institute of Oncology by combining Merus' proprietary Biclonics technology platform with VHIO's expertise in clinical, translational and preclinical research.
Furthermore, Zymeworks Inc. announced the initiation of clinical development of its first product, known as ZW49, by utilizing the ZymeLink ADC platform in combination with Zymeworks' Azymetric bispecific platform. The Company is expected to file an IND application to begin trials of ZW49 for the treatment of HER2-expressing cancers.
Similarly, Simcere Pharmaceutical is also planning to develop and commercialize three bi-specific antibodies in China. In order to carry out this research, Simcere will make of use Merus N.V's proprietary Biclonics technology platform. In this deal, Merus will retain the rights on these three bi-specific antibodies outside China.
As per RNCOS latest research reports, many more new biopharmaceutical companies are expected to enter the market in the coming years. Increasing application of bi-specific antibodies in drug development is expected to further increase the revenues of the key players in Global Bi-Specific Antibodies Market.
RNCOS has over a decade of experience in Healthcare Market Reports. We can act as a potential growth partner in all your business endeavours, such as product launching, geographic expansion, sales improvement, distributor/
Feel free to download the latest sample: http://rncos.viewpage.co/
Check Related REPORTS on: http://www.rncos.com/
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
RNCOS E-Services Pvt. Ltd.
G - 199, Sector - 63, Noida – 201301